Feed SKIN
SK

SkinHealth Systems Inc. SKIN NASDAQ · Healthcare · United States

$12.46 -10.23% -$1.42

Market cap
$90.4M
Enterprise value
$242.2M
P/E
-
Forward P/E
-
PEG
-
P/S
0.3x
P/FCF
4.9x
EV/EBITDA
7.3x
ROIC
3.0%
Gross margin
67.2%
Net margin
-6.3%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
4.6x
Beta
1.06
Free float
61.6%

Sector

Healthcare

Industry

Medical - Specialties

CEO

Pedro Malha

Employees

613

Headquarters

Long Beach

Valuation

Is today's price reasonable?

  • What speaks for it: The share price is below the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

  • What speaks for it: It beat profit estimates 7 times in the last 8 quarters.
  • What to watch: Revenue fell by 6.3% a year over the last 3 years.
  • What to watch: Analysts expect revenue to fall by 5.2% this fiscal year.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What to watch: The company made a loss over the last 12 months.

Financial health

Can it carry its debt?

  • What to watch: Operating profit does not even cover the interest on its debt.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy